3D Medicines Balance Sheet Health
Financial Health criteria checks 3/6
3D Medicines has a total shareholder equity of CN¥870.7M and total debt of CN¥230.6M, which brings its debt-to-equity ratio to 26.5%. Its total assets and total liabilities are CN¥1.4B and CN¥558.2M respectively.
Key information
26.5%
Debt to equity ratio
CN¥230.62m
Debt
Interest coverage ratio | n/a |
Cash | CN¥996.58m |
Equity | CN¥870.69m |
Total liabilities | CN¥558.20m |
Total assets | CN¥1.43b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1244's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥500.4M).
Long Term Liabilities: 1244's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥57.8M).
Debt to Equity History and Analysis
Debt Level: 1244 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 1244's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 1244 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1244 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.